Inactive Instrument

Echo Therapeutics Inc Stock price Nasdaq

Equities

US27876L2060

Advanced Medical Equipment & Technology

Dynamic Chart
Managers TitleAgeSince
Director of Finance/CFO 65 14-12-28
Members of the board TitleAgeSince
Director of Finance/CFO 65 14-12-28
More insiders
Echo Therapeutics, Inc. is a medical device company. The Company is engaged in developing a non-invasive, wireless continuous glucose monitoring (CGM) system with use in the wearable-health consumer market, diabetes outpatient market and in the hospital setting. The Company operates through the development of transdermal skin permeation and diagnostic medical devices segment. The Company has also developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, enhanced delivery of topical pharmaceuticals and other applications. The CGM System includes a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. The Company has conducted several human feasibility clinical studies with its CGM System in healthy subjects, diabetics and critically ill patients, as well as a clinical study at several hospitals in the United States.
More about the company
  1. Stock
  2. Equities
  3. Stock Echo Therapeutics, Inc.
  4. Stock Echo Therapeutics Inc - Nasdaq